Furthermore, the focus of most research on ctDNA mutations in lung cancer patients has been limited to a few genes that are frequently mutated in lung cancers with clinical implications, namely EGFR and KRAS17, 21, 22, 23. This evidence concerns the gene EGFR and lung cancer.